Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.471
Delayed Data
As of Aug 04
 -0.004 / -0.84%
Today’s Change
0.43
Today|||52-Week Range
1.04
-35.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization20.4K45.8K50.4K47.7K
 
 
 
 
 
 
Operating ExpensesGross Income-20.4K-45.8K-50.4K-47.7K
 
 
 
 
 
General Expenses8.6M11.8M9.4M9.8M
 
 
 
 
 
Research And Development5.0M7.7M5.3M6.0M
 
 
 
 
 
Total Operating Expenses8.6M11.8M9.5M9.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.6M-11.8M-9.5M-9.9M
 
 
 
 
 
Extraordinary Credit2.9M0.00642.4K529.8K
 
 
 
 
Extraordinary Charge0.00-2.3M0.00--
 
 
Other Expenses0.00-397.3K0.00-62.7K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-14.5M-8.8M-9.4M
 
 
 
 
 
Net Income-5.7M-14.5M-8.8M-9.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.5M41.8M54.3M59.9M
 
 
 
 
 
Shares To Calculate EPS Diluted27.5M41.8M54.3M59.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.35-$0.16-$0.16
 
 
 
 
 
EPS Diluted-$0.21-$0.35-$0.16-$0.16